New product: Ilaxten (bilastine) 2.5 mg/ml oral solution

This new presentation of bilastine (20mg tablets and 10mg orodispersible tablets also available) is licensed for the symptomatic treatment of allergic rhino-conjunctivitis (seasonal and perennial) and urticarial in children aged 6 to 11 years with a body weight of at least 20 kg

electronic Medicines compendium